Insider · CIK 0001953660
Kuk Hyoun Hwang
Files at OSRH (OSR Holdings, Inc.). First filing -, latest -.
In brief
Kuk Hyoun Hwang files SEC Form 4 as CEO, president, director and 10% owner at OSRH (OSR Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kuk Hyoun Hwang has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | OSRH OSR Holdings, Inc. | JOther Common Stockindirect: By Bellevue Global Life Sciences Investors LLC | +43,000 | $0.00 | $0 | 2,043,500 | Feb 19, 2025 |
| Feb 14, 2025 | OSRH OSR Holdings, Inc. | JOther Common Stockindirect: By BCM Europe AG | +7,531,634 | $0.00 | $0 | 9,575,134 | Feb 19, 2025 |
| Feb 14, 2025 | OSRH OSR Holdings, Inc. | JOther Common Stockindirect: By Bellevue Capital Management LLC | +3,123,970 | $0.00 | $0 | 12,699,104 | Feb 19, 2025 |
Questions about Kuk Hyoun Hwang
Answered from the filings on this page, as of the latest one.
Is Kuk Hyoun Hwang buying or selling?
Kuk Hyoun Hwang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kuk Hyoun Hwang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kuk Hyoun Hwang has 0.
Where does Kuk Hyoun Hwang file Form 4?
Kuk Hyoun Hwang has filed Form 4 at OSRH (OSR Holdings, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.